The Promise of Regenerative Medicine and AI
— CERN Knowledge Transfer Seminar with Peter Egelberg
Today, treatments based on laboratory-cultured cells are curing cancer patients. Besides cancer, cell-based therapies have the potential to heal and rejuvenate patients suffering from diseases like Parkinson’s, Alzheimer’s, diabetes and heart disease. In parallel, the technology behind artificial neural networks has made strides in the past years. Jointly, these seemingly unrelated technologies could transform healthcare as we know it. Digital technologies in AI, developed at CERN for high-energy physics, might be promising for this field.
During this seminar, Peter Egelberg, Founder of Phase Holographic Imaging (PHI), will present the work carried out by PHI in the development of time-lapse cytometry instrumentation and software.
“Scientists at CERN have developed techniques that rapidly filter out interesting information among the uninteresting. I was invited to CERN to speak about how these AI-based techniques can be applied to regenerative medicine and cell-therapy manufacturing in particular.”Peter Egelberg